about
Motion correction of multi-frame PET data in neuroreceptor mapping: simulation based validation.Resting brain activity varies with dream recall frequency between subjects.Switching brain serotonin with oxytocin.5-HT1A gene promoter polymorphism and [18F]MPPF binding potential in healthy subjects: a PET study.Advanced [(18)F]FDG and [(11)C]flumazenil PET analysis for individual outcome prediction after temporal lobe epilepsy surgery for hippocampal sclerosis.A multi-atlas based method for automated anatomical rat brain MRI segmentation and extraction of PET activityMulti-atlas attenuation correction supports full quantification of static and dynamic brain PET data in PET-MR.Mechanisms leading to reversible mechanical dysfunction in severe CAD: alternatives to myocardial stunning.Selective serotonin 5-HT1A receptor biased agonists elicitdistinct brain activation patterns: a pharmacoMRI studyTask-independent semantic activation for numbers and animals.Imaging Dopamine and Serotonin Systems on MPTP Monkeys: A Longitudinal PET Investigation of Compensatory Mechanisms.Pseudo-CT generation in brain MR-PET attenuation correction: comparison of several multi-atlas methods.Brain opioid receptor density predicts motor cortex stimulation efficacy for chronic pain.Relief of dyspnea involves a characteristic brain activation and a specific quality of sensation.Motor cortex stimulation for pain control induces changes in the endogenous opioid system.On the relation between sensory deafferentation, pain and thalamic activity in Wallenberg's syndrome: a PET-scan study before and after motor cortex stimulation.Activity in the rat olfactory cortex is correlated with behavioral response to odor: a microPET study.Association between triallelic polymorphism of the serotonin transporter and [18F]MPPF binding potential at 5-HT1A receptors in healthy subjects.A multi-atlas based method for automated anatomical Macaca fascicularis brain MRI segmentation and PET kinetic extraction.Behavioural impact of a double dopaminergic and serotonergic lesion in the non-human primate.Non-motor dopamine withdrawal syndrome after surgery for Parkinson's disease: predictors and underlying mesolimbic denervation.Increased left striatal dopamine transmission in unaffected siblings of schizophrenia patients in response to acute metabolic stress.Muscarinic receptor upregulation in patients with myocardial infarction: a new paradigm.Differential brain opioid receptor availability in central and peripheral neuropathic pain.Young-onset Parkinson disease with and without parkin gene mutations: a fluorodopa F 18 positron emission tomography study.Cardiac retention of [11C]HED in genotyped long QT patients: a potential amplifier role for severity of the disease.Chronic subthalamic nucleus stimulation and striatal D2 dopamine receptors in Parkinson's disease--A [(11)C]-raclopride PET study.5-HT1A receptor binding and intracerebral activity in temporal lobe epilepsy: an [18F]MPPF-PET study.Statistical parametric mapping of 5-HT1A receptor binding in temporal lobe epilepsy with hippocampal ictal onset on intracranial EEG.Effect of sensory stimulus on striatal dopamine release in humans and cats: a [(11)C]raclopride PET study.Role of dopaminergic treatment in dopamine receptor down-regulation in advanced Parkinson disease: a positron emission tomographic study.Brain processing of visual sexual stimuli in treated and untreated hypogonadal patients.Positron emission tomography with α-[11C]methyl-L-tryptophan in tuberous sclerosis complex-related epilepsy.Seizure-related short-term plasticity of benzodiazepine receptors in partial epilepsy: a [11C]flumazenil-PET study.Comorbidity between temporal lobe epilepsy and depression: a [18F]MPPF PET study.Interictal brain 5-HT1A receptors binding in migraine without aura: a 18F-MPPF-PET study.Organic background of restrictive-type anorexia nervosa suggested by increased serotonin 1A receptor binding in right frontotemporal cortex of both lean and recovered patients: [18F]MPPF PET scan study.Striatal dopamine during sensorial stimulations: a [18F]FDOPA PET study in human and cats.Increased serotonin receptor availability in human sleep: evidence from an [18F]MPPF PET study in narcolepsy.Decreased [18F]MPPF binding potential in the dorsal raphe nucleus after a single oral dose of fluoxetine: a positron-emission tomography study in healthy volunteers.
P50
Q33456336-69FEBA3D-61FD-4619-BEBE-0008BB19FDA0Q33620639-507A8C65-EAED-4EAA-9B7A-AF07B8A8C71FQ33767701-28DB0850-8BA1-412C-B783-F67F83AC6186Q34019984-00ACAE56-44EA-4CD1-8668-F36B5344A6C3Q34988481-9B5AE004-86B8-45A3-AF03-C7554D852C11Q35349838-F6EE3838-F244-431F-8EAE-7450591D6900Q36274951-FC2ED280-5FF2-4BBE-8534-9093906DA8DEQ36544287-4EA06CFB-1628-41D1-966C-402283B23C94Q36925361-724C5177-2AF9-484C-BD94-1E316F6475B0Q38414104-0C104048-6E32-4E7A-A705-68A9EB9996FEQ38912305-22A1FAE6-B432-4660-BA6C-DC25DDA16E79Q39181223-C208F367-64F3-425D-B2A2-2432BFCF078AQ39222940-DB00FC59-AEBB-4EFF-90EE-BEB3D6C0E2E0Q39326880-D21B6C4B-6DB8-488D-9B58-64CCA3822532Q39331169-63C52A6A-8A5A-4442-8FF7-14348B4E2F9AQ39358090-A9F19A1E-DA2A-4805-8BC3-BAE14B16C3D5Q39754646-E28BBF44-A1C5-4A19-9B60-1A651687E195Q39983098-624DD041-39A5-48CC-A447-9DA65219E50AQ40101472-2DC661F2-EF3A-426B-B600-84204C64B3D6Q40790760-691B2DA8-8EBC-47D0-A717-E8AEEDF4574BQ43125929-087C676A-5854-42AA-B7AD-D3095BD26809Q43192020-2EA661F5-08E3-4322-87BC-EBB9C365C3E2Q43266218-2BC7DDFA-E2E5-43BB-B739-1F1B2C82E64DQ44332987-E87D86B8-36A1-45A7-AFDB-764A5186F0CFQ44447062-E03E0EE0-4A8A-4A9B-B936-1F94B1337519Q44459153-F18BEAE2-0FC3-4D9B-851E-1DD2D776B982Q44637463-E51ADF13-5A8D-4203-90D7-36E5D1B65F70Q44777334-8CBE8D2B-5B18-4EFD-8DCA-6319227B2823Q44933449-5F946E3E-1491-42F6-B786-7E26B330E2B2Q45040558-D8B4B58C-F18B-42EA-A765-7278B2CDFA62Q45144710-339CF06B-E0A9-4CD9-8828-E24C4052EC33Q45274029-C5F8C195-5284-4DC9-8E41-28F877A3EDB1Q46047591-3B6CAF58-2827-4AE1-8596-4DD85195A0D7Q46367786-31596540-D2C6-4F22-BEE6-7BA5D1B2CFDDQ46395612-079CD506-AD48-4FB1-ACC7-BC6BEAB83B2CQ46411098-EFBD9BB1-A763-416D-9F89-C774B7DDE799Q46474452-0A48A826-DDE9-4A9A-86A2-1DCE4405799AQ46528510-9C42D207-2E1D-4D0D-B665-76D5FC88FF19Q46794373-1993960A-D0A5-4747-A7A1-137772DF3EBCQ46810724-6A2190A7-4567-4720-AB69-ECD9FA9C1450
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Nicolas Costes
@ast
Nicolas Costes
@en
Nicolas Costes
@es
Nicolas Costes
@nl
Nicolas Costes
@sl
type
label
Nicolas Costes
@ast
Nicolas Costes
@en
Nicolas Costes
@es
Nicolas Costes
@nl
Nicolas Costes
@sl
prefLabel
Nicolas Costes
@ast
Nicolas Costes
@en
Nicolas Costes
@es
Nicolas Costes
@nl
Nicolas Costes
@sl
P1053
D-4452-2013
P106
P21
P2456
P31
P3829
P496
0000-0002-2954-9262